Neurocrine Biosciences Inc (NBIX)

Financial leverage ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Total assets US$ in thousands 3,718,700 3,251,400 2,368,700 2,072,500 1,734,700
Total stockholders’ equity US$ in thousands 2,589,700 2,232,000 1,707,800 1,374,000 1,126,200
Financial leverage ratio 1.44 1.46 1.39 1.51 1.54

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $3,718,700K ÷ $2,589,700K
= 1.44

The financial leverage ratio for Neurocrine Biosciences Inc has shown a slight decreasing trend over the years, declining from 1.54 in December 2020 to 1.44 in December 2024. This indicates that the company's reliance on debt to finance its operations and growth has decreased gradually. However, the ratio remains above 1, suggesting that there is still some level of financial leverage in the company's capital structure. Overall, the trend indicates a moderate level of financial leverage that is being managed effectively by the company.